Literature DB >> 14991042

Aurora kinases dawn as cancer drug targets.

Edward A Sausville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14991042     DOI： 10.1038/nm0304-234

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

Review 1.  Recent advances in the development of Aurora kinases inhibitors in hematological malignancies.

Authors:  Iqra Choudary; Paul M Barr; Jonathan Friedberg
Journal:  Ther Adv Hematol       Date:  2015-12

Review 2.  Why Great Mitotic Inhibitors Make Poor Cancer Drugs.

Authors:  Victoria C Yan; Hannah E Butterfield; Anton H Poral; Matthew J Yan; Kristine L Yang; Cong-Dat Pham; Florian L Muller
Journal:  Trends Cancer       Date:  2020-06-11

3.  Synthesis and investigation of new Hesperadin analogues antitumor effects on HeLa cells.

Authors:  Fereshteh Shamsipour; Saeeideh Hosseinzadeh; Seyed Shahriar Arab; Sedigheh Vafaei; Samira Farid; Mahmood Jeddi-Tehrani; Saeed Balalaie
Journal:  J Chem Biol       Date:  2014-05-18

4.  Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT.

Authors:  Enke Baldini; Yannick Arlot-Bonnemains; Salvatore Sorrenti; Caterina Mian; Maria R Pelizzo; Enrico De Antoni; Silvio Palermo; Stefania Morrone; Susi Barollo; Angela Nesca; Costanzo G Moretti; Massimino D'Armiento; Salvatore Ulisse
Journal:  BMC Cancer       Date:  2011-09-26       Impact factor: 4.430

Review 5.  Non-centrosomal TPX2-Dependent Regulation of the Aurora A Kinase: Functional Implications for Healthy and Pathological Cell Division.

Authors:  Georgina Garrido; Isabelle Vernos
Journal:  Front Oncol       Date:  2016-04-15       Impact factor: 6.244

6.  Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients.

Authors:  Raffaele Pezzani; Loris Bertazza; Elisabetta Cavedon; Simona Censi; Jacopo Manso; Sara Watutantrige-Fernando; Gianmaria Pennelli; Francesca Galuppini; Susi Barollo; Caterina Mian
Journal:  Int J Endocrinol       Date:  2019-02-18       Impact factor: 3.257
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.